|
⚲
|
| Keyboard |
| Daniel Estes | |
|---|---|
| Firm | Frazier Life Sciences Management LP |
| Address | 1001 Page Mill Road, Building 4, Suite B Palo Alto, CA 94304 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Frazier Life Sciences Management LP | |||||
| Frazier Life Sciences XII LP | 021-541158 | Executive Officer | 1,350.6 M | ||
| Frazier Life Sciences Xi LP | 021-438073 | Executive Officer | 960.0 M of 960.0 M |
1,107.8 M | |
| Frazier Life Sciences IX LP | 021-297918 | Promoter | 418.9 M of 418.9 M |
596.5 M | |
| Eyconis Inc | 021-504724 | Executive Officer | 60.3 M of 150.0 M |
||
| SUDO Biosciences Inc | 021-501000 | Director | 63.6 M of 161.8 M |
||
| SUDO Biosciences Inc | 021-398288 | Director | 22.2 M of 22.2 M |
||
| Arcutis Biotherapeutics Inc | 021-351627 | Director | 94.5 M of 94.5 M |
||
| Outpost Medicine LLC | 021-287636 | Director | 56.0 M of 56.0 M |
||
| Cirius Therapeutics Inc | 021-284449 | Director | 30.0 M of 40.5 M |
||
| Outpost Medicine LLC | 021-260210 | Director | 15.5 M of 41.5 M |
||